RADX RADX
Company Profile ↓Company Overview
RADX (RADX) is a publicly traded company listed on with a market capitalization of $6.57B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 643.8% CAGR over the past five years.
Recent Developments
- Jun 2025 Revenue of $3.63M (+1114.3% YoY); net profit $-38.34M.
- Trailing 12 Months Year-on-year growth — revenue +1114.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 643.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 643.76% |
| 1 Year: | 1,114.27% |
Stock Price Performance
| 1 Year: | -44.94% |
| 6 Months: | -42.92% |
| 3 Months: | -39.43% |
| 1 Month: | -34.43% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)20.41 · Oversold
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 643.8% over 5 years.
CONS
- Trading 73.8% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
- RSI at 20 suggests oversold conditions.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 8.83K | 292.36K | 299.23K | 3.63M |
| Cost of Revenue | - | 0 | 0 | 3.59M |
| Gross Profit | 8.83K | 292.36K | 299.23K | 39.28K |
| Operating Expenses | 19.93M | 31.98M | 37.47M | 34.68M |
| Operating Income | -19.92M | -31.69M | -37.17M | -34.64M |
| EBITDA | -17.96M | -34.48M | -47.20M | -38.17M |
| Interest Expense | 9.35M | 86.09K | 642.89K | 65.30K |
| Pretax Income | -30.29M | -34.57M | -47.85M | -38.24M |
| Tax Provision | 44.40K | 38.01K | 96.36K | 103.29K |
| Net Income | -30.34M | -34.61M | -47.95M | -38.34M |
| Diluted EPS | -45.85 | -32.07 | -37.23 | -5.28 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Total Assets | 83.38M | 74.95M | 72.04M | 86.48M |
| Current Assets | 27.26M | 16.30M | 22.85M | 39.85M |
| Cash & Equivalents | 26.98M | 11.70M | 18.58M | 29.12M |
| Inventory | - | - | - | - |
| Receivables | 56.48K | 104.71K | 802.99K | - |
| Total Liabilities | 20.42M | 29.37M | 44.68M | 43.61M |
| Current Liabilities | 7.88M | 13.23M | 17.58M | 14.93M |
| Long Term Debt | - | - | - | - |
| Total Debt | - | - | - | - |
| Total Equity | 62.96M | 44.38M | 28.12M | 44.79M |
| Shares Outstanding | 279.77M | 359.27M | 460.37M | 2.36B |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - |
| Investing Cash Flow | -28.37M | -1.53M | -320.00K | 1.77M |
| Financing Cash Flow | 65.11M | 9.22M | 30.20M | 45.43M |
| Capital Expenditure | -28.34M | -1.53M | - | - |
| Free Cash Flow | -38.25M | -24.73M | -22.98M | -36.65M |
| Net Change in Cash | 26.82M | -15.51M | 6.90M | 10.56M |
Ratios (Annual)
Figures in %.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Gross Margin % | 100.0% | 100.0% | 100.0% | 1.1% |
| Operating Margin % | -225,527.7% | -10,839.6% | -12,423.3% | -953.4% |
| Net Margin % | -343,550.9% | -11,838.6% | -16,024.3% | -1,055.3% |
| ROE % | -48.2% | -78.0% | -170.5% | -85.6% |
| ROCE % | -26.4% | -51.3% | -68.3% | -48.4% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for RADX
RADX Stock Price and Chart — NASDAQ:RADX - TradingView
<a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE10LXdGbVF1TEdLMFZWelE5VHgyNi16UjkxdnEyNEl2R3YzaFkwV0xHWkJ5WGMxZ1BSRlBvVURzY19OMzE3NHRDQnBQUHNLNHNnOVYxcGhaXzdULWUzOTNPZmVrOUR0ZUM3YjQ3RHhoOA?oc=5" target="_blank">RADX Stock Price …
RADX: RAD101 Topline & FY:26 Cash Flows - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxPWDZRSGUtMUQ1TTVZcW05VTgyTFZQVmxkdUJIZ09MTHUyUVhEWlFtSzk4dkJsSVg3b2Zoc0xoR051M0xycnNNRW14cVZqOFU0ZUFyU25vcEFtMzFlVUdqUF9jY1pkN3lQUlVRc002TWRiYlhDYjl6YThBaFFnY0JvRVZCQkczS0l1XzNDTk…
RADX Stock Soars: Is It Time to Buy? - StocksToTrade
<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxOVElUWWtUQ2FKVHVWWTc3TXg5WDZKTGs4b1NsWTF4X09fLVhnamdnYkh0bnhEMnR1alVRd0pPbzlxcXBTV3hTclpvQ3Jzbk5qMm1pSWpmT0ZkenpYUkhPYjdDVjN2dWwxNVhvbEltU0RURWlsV3J2MXN0VGx0OFZGSjVnbnk1MzR2MEtsYQ…
Radiopharm Theranostics Ltd (RADX) Income Statement - TradingKey
<a href="https://news.google.com/rss/articles/CBMicEFVX3lxTFBMZ2lRVGRZbnFNeEFPUG1KX0JVSGVvNEY1VnRBNVpLZl9Ra1YtZFhqQjlCUDI5U2xvelczU1dzMmdWRjh4Q0JGdlEtd3pLZXRjM0VVekhVVG5UMkJIYUFhRzZlbGkwNTNoSEh2Z3VwTno?oc=5" target="_blank">Radiopharm Thera…
Radiopharm: 'Hold' As Theranostics Pipeline Has Several 2026 Milestones (NASDAQ:RADX) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxNSWFjcEJ3Mm5abHpWNTRBQi0tXzVkcXBBZTlKQkpkRTlPeVlpc2RtMHJxaTV2UTUyMGdVUzU3TzM4dm12cDdvSW13OVpfbTFvZkhwX3Fwd1NrVnJOeVlvRVZ0ZVlqM09tbXRvRmhjajFSaUNKaVY5UjV4TGYtVXBVRFpTRWNOZVdYOFczcV…
Radiopharm Dips on Securities Pact - Baystreet.ca
<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxOTnNLUVNKdjlNSjh2b1BUYXV0YUFpYUNBSnpzQ0tQd0dQdXF4MEE2cE5hOHRaVy1hZDJkUkNteEp1bmQwME8wQzJZYkl5d2pkYWd3akhqMUZNZ1h3b3cwREdIQl9GNHlMNmEzVHlNTTNVVXJHZHl2QlVXMmZmUXRZVWJfbFA5d9IBfkFVX3…
RADX — Frequently Asked Questions
What is the current share price of RADX?
As of 2026-08-05 17:25 PDT, RADX trades at $2.78 on NASDAQ/NYSE. Its 52-week range is $2.78 to $10.63.
What is the market capitalisation of RADX?
RADX has a market capitalisation of $6.57B on NASDAQ/NYSE.
What is the P/E ratio of RADX?
RADX trades at a trailing price-to-earnings (P/E) ratio of -0.53. Its price-to-book (P/B) ratio is 147.09.
What is the return on equity (ROE) of RADX?
RADX has a return on equity (ROE) of -85.60%. Its return on capital employed (ROCE) is -48.42%.
Is RADX a good stock to buy?
This page provides a data-driven analysis of RADX, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.